Tardive Dyskinesia Mechanism
Dec. 25, 2024
Mechanism of action of vesicular monoamine transporter 2 (VMAT2) inhibitors in tardive dyskinesia: reducing dopamine leads to less “go” and more “stop” from the motor striatum for robust therapeutic effects | CNS Tardive Dyskinesia Symptoms and Information - YouTube PDF] Deuterium Tetrabenazine for Tardive Dyskinesia. | Semantic Scholar Tardive Dyskinesia | A Drug Pipeline Analysis Report 2018 | Technavio | Business Wire | Tardive Dyskinesia Mechanism